A comprehensive characterization of genome-wide copy number aberrations in colorectal cancer reveals novel oncogenes and patterns of alterations.
To develop a comprehensive overview of copy number aberrations (CNAs) in stage-II/III colorectal cancer (CRC), we characterized 302 tumors from the PETACC-3 clinical trial. Microsatellite-stable (MSS) samples (n = 269) had 66 minimal common CNA regions, with frequent gains on 20 q (72.5%), 7 (41.8%)...
Main Authors: | Tao Xie, Giovanni D' Ario, John R Lamb, Eric Martin, Kai Wang, Sabine Tejpar, Mauro Delorenzi, Fred T Bosman, Arnaud D Roth, Pu Yan, Stephanie Bougel, Antonio Fabio Di Narzo, Vlad Popovici, Eva Budinská, Mao Mao, Scott L Weinrich, Paul A Rejto, J Graeme Hodgson |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3409212?pdf=render |
Similar Items
-
Connecting gene expression subtypes of colorectal cancer (CRC) with cell lines and drug resistance.
by: Budinska, E, et al.
Published: (2013) -
A critical comparison of topology-based pathway analysis methods.
by: Ivana Ihnatova, et al.
Published: (2018-01-01) -
Cell Line Derived 5-FU and Irinotecan Drug-Sensitivity Profiles Evaluated in Adjuvant Colon Cancer Trial Data.
by: Ida Kappel Buhl, et al.
Published: (2016-01-01) -
Oncogenic structural aberration landscape in gastric cancer genomes
by: Mihoko Saito-Adachi, et al.
Published: (2023-06-01) -
Quantifying the driverness of copy number aberrations in prostate cancer
by: Al-Muftah, NJ
Published: (2024)